http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Siamak Moradian, Hooshang Faghihi, Babak Sadeghi, Niloofar Piri, Hamid Ahmadieh, Masoud Soheilian, Mohammad Hossein Dehghan, Mohsen Azarmina, Mohammad Riazi Esfahani (Tehran, Iran) Advantages: To compare the visual and anatomical (central macular thickness; CMT) outcomes of intravitreal bevacizumab (IVB) injections relative to sham...
Read MoreIntravitreal Bevacizumab vs Sham Treatment in Acute Branch Retinal Vein Occlusion with Macular Edema: Short Term Results (Report 1)
Posted by Siamak Moradian, Hooshang Faghihi, Babak Sadeghi, Niloofar Piri, Hamid Ahmadieh, Masoud Soheilian, Mohammad H Dehghan, Mohsen Azarmina and M. Riazi Esfahani on Oct 1, 2010 in Bevacizumab Avastin, Branch and hemicentral vein occlusion
Memantine in Acute Nonarteritic Anterior Ischemic Optic Neuropathy
Posted by M. Riazi Esfahani, Z. Aalami, M. Gholami, A. Mirshahi and M. Movasat on Oct 1, 2008 in Optic Neuropathy
M. Riazi Esfahani, Z Aalami, Gholami, AR Tabasi, A Mirshahi, M Movasat Advantages: To introduce the neuroprotective effect of Memantine (an NMDA type glutamatergic open-channel blocker) in visual functions of patients with acute NAION (Nonarteritic anterior ischemic optic neuropathy) and comparing it with placebo. Methods: Eligible eyes were randomly allocated to either Memantine tablets (5mg daily for first week and 10mg daily for the...
Read More